Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)

NACompletedINTERVENTIONAL
Enrollment

14,989

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

February 28, 2023

Conditions
HyperkalemiaHypokalemia
Interventions
OTHER

Artificial Intelligence identified Dyskalemia using Electrocardiogram (AIDE) system

Once the AIDE indicates high risk of dyskalemia, an obvious message by scarlet letter was appeared in the HIS operation interface to corresponding physicians. To avoid the alert fatigue, we selected the cut-off points with expected positive predictive values of ≥40% according to previous data, which was the consensus of enrolled physicians before the trial considering the clinical loading. The physicians received the AIDE alerts as long as they were operating HIS logged in by their account, even if they were caring other patients. Physicians can review the AIDE predictions of patients in the intervention group. Therefore, this was a single-blind study since HIS presented different information for patients in intervention and control groups. The participated physicians understood the likelihood of dyskalemia and cardiac risk for those patients with ECG-dyskalemia, and provided suitable medical care according to patients' conditions.

Trial Locations (1)

114

National Defense Medical Center, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER

NCT05118022 - Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) | Biotech Hunter | Biotech Hunter